Basel Medical Group Ltd Ordinary Shares

BMGL | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.04

+$0.29 (+6.11%)

At close: Oct 30, 2026, 4:00 PM ET

$5.00

-$0.04 (-0.79%)

Pre-market: Nov 2, 2026, 9:25 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $7.97M

Enterprise Value $18.78M

Beta 0.26

Average Volume 580.44K

Shares Outstanding (Diluted) 1.57M

Shares Change YoY N/A

Institutional Ownership N/A

Exchange NASDAQ

ISIN VGG0864B1114

Price Performance

Price Change 1M 61.5%

Price Change 3M -10.3%

Price Change 6M -25.0%

Price Change YTD -14.3%

Price Change 1Y -72.2%

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) 9.3%

1Y CAGR (ann.) -72.5%

5Y CAGR (ann.) N/A

All-Time CAGR -75.5%

Valuation

PE Ratio -18.79

Forward PE N/A

PEG Ratio -0.24

Forward PEG -0.24

PS Ratio 0.73

Forward PS N/A

PB Ratio 1.63

P/FCF Ratio -4.04

P/Adj. FCF Ratio -4.04

P/OCF Ratio -3.74

EV/Sales 1.31

EV/EBIT -4.15

EV/EBITDA -11.20

EV/FCF -7.29

Earnings Yield -5.4%

FCF Yield -25.3%

Adj. FCF Yield -25.3%

Financial Health

Net Debt S$4.5M

Total Debt S$9.87M

Cash & Short-Term Investments S$1.34M

Total Assets S$20.12M

Current Ratio 1.88

Quick Ratio 1.84

Debt / Equity Ratio 1.57

Debt / EBITDA -5.89

Debt / FCF -3.83

OCF / Debt -0.20

Interest Coverage -13.00

Altman Z-Score -1.14

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.3%

Operating Profit Margin -31.7%

EBITDA Margin -16.0%

Net Profit Margin -51.5%

FCF Margin -18.0%

Adj. FCF Margin -18.0%

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets -47.4%

Return on Equity -164.2%

Return on Invested Capital -24.8%

Return on Capital Employed -32.8%

Return on Tangible Assets -47.4%

Historical Growth (CAGR)

Revenue CAGR 3Y 2.0%

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -300.2%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -1506.4%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $0.00

Price Target Upside N/A

Cash Flow

Operating Cash Flow S$-1.93M

Free Cash Flow S$-2.58M

Adj. Free Cash Flow S$-2.58M

FCF Per Share -$2.21

OCF Per Share -$1.76

OCF/S Ratio -14.9%

Income Statement

Revenue S$14.29M

Gross Profit S$-339K

Operating Income S$-4.53M

EBITDA S$-1.68M

Net Income S$-9.67M

EPS (Diluted) -$0.35

Revenue / Employee $174.32K

Profit / Employee $-117.94K

Employees 82